NEW

FDA clears first fully disposable duodenoscope, eliminating the potential for infections caused by ineffective reprocessing

The U.S. Food and Drug Administration today cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct...

Webinar Addresses ‘Hot Topic’

The recent OR Today webinar “Human Factors and Quality Testing for Device Reprocessing” was sponsored by Healthmark and eligible for one (1) continuing education (CE) hour by the State of California Board of Registered Nursing. The 60-minute webinar featured Jahan...

Nihon Kohden Introduces First Subscription-Based Pricing for Patient Monitoring, Neurology Products

Nihon Kohden, a U.S. market leader in precision medical products and services, has launched subscription-based pricing models for its patient monitoring and neurology products, the first in the industry to take such a step. The pricing models help align costs with...

Nihon Kohden Launches Life Scope SVM-7200 Series

Nihon Kohden has announced the launch of its Life Scope SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds that traditionally are not continuously monitored. The monitor allows health care practitioners to quickly and easily...

Nextgen UV Technology Reduces Infections

In a peer-reviewed study published in the December issue of American Journal of Infection Control, researchers documented that using Infection Preven-tion Technologies (IPT) NextGen UV disinfection robots and a dedicated team of trained operators resulted in signifi cant reductions of healthcare-ac-quired infections. The study was conducted over a six-month period at Hollywood Community Hospital/Brotman Medical Center Campus.

Several factors make the study notable. It is peer-reviewed and demonstrated signifi cant reductions in multiple harmful pathogens including a 42.7 percent decrease in the incidence of Clostridium diffi cile infections, 71.4 percent decrease in Acinetobacter baumannii infections, and a 100 percent drop in Klebsiella pneumoniae infections. The overall HAI incidence rate was reduced 34.2 percent during the intervention period

“While many studies highlight a disease reduction in a small area of the hospital, this study was conducted hospital-wide,” Tom Kenny, IPT’s CEO noted. “Ninety-five percent of the rooms in the entire facility were treated. These results are compelling evidence for the effi cacy of our state-of-the-art UV robots and the benefi ts of using skilled robot operators.”

“Not only is the ROI demonstrably high but based on the total reduction of HAI incidents and the average cost of an HAI re-admission, the derived cost-savings is nearly $250,000 in just six months. That’s huge,” Kenny continued. “The bottom line is serious cost avoidance and a much safer environment for both patients and staff .” •

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X